See more : Aso Foam Crete Co., Ltd. (1730.T) Income Statement Analysis – Financial Results
Complete financial analysis of Fuse Medical, Inc. (FZMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fuse Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- The Motor & General Finance Limited (MOTOGENFIN.NS) Income Statement Analysis – Financial Results
- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Income Statement Analysis – Financial Results
- Trustco Group Holdings Limited (TSCHY) Income Statement Analysis – Financial Results
- Ujjivan Small Finance Bank Limited (UJJIVANSFB.BO) Income Statement Analysis – Financial Results
- Exxon Mobil Corporation (XOM.NE) Income Statement Analysis – Financial Results
Fuse Medical, Inc. (FZMD)
About Fuse Medical, Inc.
Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.12M | 18.64M | 20.41M | 21.40M | 22.90M | 26.34M | 26.41M | 567.61K | 1.68M | 941.09K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 156.82K | 1.00K | 10.00K | 0.00 | 0.00 | 30.00K | 0.00 | 10.00K | 0.00 | 4.31M | 10.25M | 11.67M | 15.68M | 16.19M | 19.68M | 25.00M |
| Cost of Revenue | 5.38M | 7.10M | 8.48M | 8.69M | 11.76M | 13.35M | 14.58M | 204.04K | 664.27K | 485.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.34M | 8.66M | 8.73M | 12.29M | 12.80M | 15.58M | 20.13M |
| Gross Profit | 10.73M | 11.54M | 11.94M | 12.70M | 11.14M | 12.99M | 11.82M | 363.56K | 1.01M | 455.70K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 156.82K | 1.00K | 10.00K | 0.00 | 0.00 | 30.00K | 0.00 | 10.00K | 0.00 | 970.00K | 1.59M | 2.94M | 3.39M | 3.39M | 4.10M | 4.87M |
| Gross Profit Ratio | 66.61% | 61.90% | 58.47% | 59.37% | 48.63% | 49.31% | 44.78% | 64.05% | 60.38% | 48.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 100.00% | 0.00% | 100.00% | 0.00% | 22.51% | 15.51% | 25.19% | 21.62% | 20.94% | 20.83% | 19.48% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 6.54M | 7.01M | 6.54M | 8.47M | 8.47M | 11.00M | 854.05K | 1.80M | 1.47M | 109.28K | 101.61K | 123.16K | 167.26K | 121.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 195.21K | 355.05K | 513.00K | 140.00K | 80.00K | 60.00K | 80.00K | 90.00K | 80.00K | 310.00K | 1.69M | 2.95M | 3.05M | 3.01M | 3.46M | 3.59M | 4.26M |
| Selling & Marketing | 0.00 | 5.68M | 7.05M | 7.09M | 5.98M | 6.43M | 5.64M | 7.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.35M | 12.22M | 14.06M | 13.63M | 14.45M | 14.90M | 11.00M | 854.05K | 1.80M | 1.47M | 109.28K | 101.61K | 123.16K | 167.26K | 121.20K | 139.09K | 153.59K | 182.63K | 156.05K | 385.25K | 168.09K | 195.21K | 355.05K | 513.00K | 140.00K | 80.00K | 60.00K | 80.00K | 90.00K | 80.00K | 310.00K | 1.69M | 2.95M | 3.05M | 3.01M | 3.46M | 3.59M | 4.26M |
| Other Expenses | 0.00 | 137.40K | 67.64K | 104.14K | 107.07K | 49.69K | 14.52K | 0.00 | 0.00 | 1.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 518.00 | 1.56K | 134.00K | 60.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -70.00K | 50.00K | 1.02M | 380.00K | 490.00K | 650.00K | 740.00K | 970.00K |
| Operating Expenses | 10.35M | 12.36M | 14.13M | 13.73M | 14.56M | 14.95M | 11.01M | 854.05K | 1.80M | 1.47M | 109.28K | 101.61K | 123.16K | 167.26K | 121.20K | 139.09K | 153.59K | 182.63K | 156.05K | 385.25K | 168.09K | 195.72K | 356.61K | 647.00K | 200.00K | 80.00K | 60.00K | 80.00K | 90.00K | 80.00K | 240.00K | 1.74M | 3.97M | 3.43M | 3.50M | 4.11M | 4.33M | 5.23M |
| Cost & Expenses | 15.73M | 19.46M | 22.61M | 22.43M | 26.32M | 28.30M | 25.59M | 1.06M | 2.47M | 1.96M | 109.28K | 101.61K | 123.16K | 167.26K | 121.20K | 139.09K | 153.59K | 182.63K | 156.05K | 385.25K | 168.09K | 195.72K | 356.61K | 647.00K | 200.00K | 80.00K | 60.00K | 80.00K | 90.00K | 80.00K | 240.00K | 5.08M | 12.63M | 12.16M | 15.79M | 16.91M | 19.91M | 25.36M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.18K | 0.00 | 30.00 | 897.00 | 9.80K | 10.83K | 57.31K | 112.75K | 94.57K | 0.00 | 0.00 | 25.51K | 40.91K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 220.58K | 171.29K | 78.23K | 94.95K | 121.63K | 133.94K | 161.67K | 129.39K | 7.11K | 71.61K | 571.00 | -101.61K | -123.16K | -167.26K | -121.20K | -139.09K | -153.59K | -182.63K | 0.00 | 0.00 | -168.09K | -185.44K | 0.00 | 0.00 | 90.00K | 100.00K | 100.00K | 110.00K | 110.00K | 70.00K | 70.00K | 0.00 | 0.00 | 0.00 | -60.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 131.57K | 137.40K | 67.64K | 104.14K | 107.07K | 49.69K | 14.52K | 19.09K | 25.07K | 13.28K | 0.00 | 30.00 | 897.00 | 9.80K | 10.83K | 57.31K | 112.75K | 94.57K | 51.94K | 19.12K | 25.51K | 518.00 | 1.56K | 134.00K | 70.00K | 210.00K | 210.00K | 210.00K | 230.00K | 140.00K | 200.00K | 180.00K | 0.00 | 0.00 | 60.00K | 0.00 | 0.00 | 0.00 |
| EBITDA | 1.84M | -677.67K | -1.42M | -1.21M | -2.31M | -1.91M | 827.19K | 3.18M | -769.37K | -1.32M | -109.28K | -101.58K | -121.92K | -157.46K | -110.36K | -81.78K | -40.84K | -88.06K | -104.11K | -366.13K | -168.09K | -164.58K | -198.23K | -369.18K | 50.00K | 130.00K | 150.00K | 160.00K | 140.00K | 70.00K | -40.00K | -590.00K | -2.39M | -500.00K | -50.00K | -720.00K | -220.00K | -350.00K |
| EBITDA Ratio | 11.39% | -3.63% | -10.42% | -4.32% | -14.46% | -7.25% | 3.13% | -83.92% | -45.74% | -106.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -123.19% | -51,800.00% | 500.00% | 0.00% | 0.00% | 533.33% | 0.00% | 700.00% | 0.00% | -13.69% | -23.32% | -4.28% | -0.32% | -4.45% | -1.12% | -1.40% |
| Operating Income | 383.82K | -815.07K | -2.20M | -1.03M | -3.42M | -1.96M | 818.04K | -492.07K | -792.03K | -1.33M | -109.28K | -101.61K | -123.16K | -167.26K | -121.20K | -139.09K | -153.59K | -182.63K | -156.05K | -385.25K | -168.09K | -195.72K | -199.79K | -646.00K | -20.00K | -80.00K | -60.00K | -50.00K | -90.00K | -70.00K | -240.00K | -770.00K | -2.39M | -500.00K | -110.00K | -720.00K | -220.00K | -350.00K |
| Operating Income Ratio | 2.38% | -4.37% | -10.75% | -4.80% | -14.92% | -7.43% | 3.10% | -86.69% | -47.24% | -141.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -127.41% | -64,600.00% | -200.00% | 0.00% | 0.00% | -166.67% | 0.00% | -700.00% | 0.00% | -17.87% | -23.32% | -4.28% | -0.70% | -4.45% | -1.12% | -1.40% |
| Total Other Income/Expenses | 1.10M | 3.94M | 625.34K | -385.59K | 882.33K | 5.53M | -118.36K | -146.92K | -9.52K | -70.44K | -571.00 | 30.00 | 897.00 | 9.80K | 10.83K | 57.31K | 112.75K | 94.57K | 51.94K | 19.12K | 25.51K | 10.28K | -5.05K | 503.83K | -90.00K | 110.00K | 110.00K | 100.00K | 120.00K | 10.00K | 130.00K | 180.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 1.48M | 3.12M | -1.57M | -1.41M | -2.54M | 3.57M | 699.68K | -585.94K | -801.55K | -1.41M | -109.86K | -101.58K | -122.26K | -157.46K | -110.36K | -81.78K | -40.84K | -88.06K | -104.11K | -366.13K | -142.57K | -185.44K | -204.85K | -503.00K | -110.00K | 30.00K | 50.00K | 50.00K | 30.00K | -60.00K | -110.00K | -590.00K | -2.39M | -500.00K | -110.00K | -720.00K | -220.00K | -350.00K |
| Income Before Tax Ratio | 9.20% | 16.74% | -7.69% | -6.61% | -11.07% | 13.56% | 2.65% | -103.23% | -47.81% | -149.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -130.63% | -50,300.00% | -1,100.00% | 0.00% | 0.00% | 166.67% | 0.00% | -600.00% | 0.00% | -13.69% | -23.32% | -4.28% | -0.70% | -4.45% | -1.12% | -1.40% |
| Income Tax Expense | 23.20K | 23.66K | 17.72K | 18.99K | 781.09K | -386.78K | 118.36K | 95.45K | 9.52K | 390.88K | 109.86K | 101.58K | 122.26K | 157.46K | 110.36K | 81.78K | 40.84K | 88.06K | 104.11K | 366.13K | 142.57K | 185.44K | 204.85K | 503.00K | 90.00K | -210.00K | -210.00K | -210.00K | -230.00K | -60.00K | -200.00K | -180.00K | 0.00 | 0.00 | 50.00K | 10.00K | 120.00K | 90.00K |
| Net Income | 1.46M | 3.10M | -1.59M | -1.43M | -3.32M | 3.96M | 699.68K | -585.94K | -801.55K | -1.41M | -109.86K | -101.58K | -122.26K | -157.46K | -110.36K | -81.78K | -40.84K | -88.06K | -104.11K | -366.13K | -142.57K | -185.44K | -204.85K | -503.00K | -200.00K | 240.00K | 260.00K | 260.00K | 260.00K | 0.00 | 90.00K | -410.00K | -2.39M | -500.00K | -160.00K | -730.00K | -340.00K | -440.00K |
| Net Income Ratio | 9.06% | 16.62% | -7.78% | -6.69% | -14.48% | 15.02% | 2.65% | -103.23% | -47.81% | -149.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -130.63% | -50,300.00% | -2,000.00% | 0.00% | 0.00% | 866.67% | 0.00% | 0.00% | 0.00% | -9.51% | -23.32% | -4.28% | -1.02% | -4.51% | -1.73% | -1.76% |
| EPS | 0.02 | 0.04 | -0.02 | -0.02 | -0.05 | 0.05 | 0.04 | -0.08 | -0.13 | -0.37 | -0.04 | -0.42 | -0.50 | -0.67 | -0.47 | -0.35 | -0.17 | -0.37 | -0.44 | -1.55 | -0.60 | -0.79 | -0.87 | -2.68 | -1.43 | 1.85 | 2.00 | 2.00 | 2.00 | 0.00 | 0.64 | -2.93 | -17.07 | -3.57 | -1.14 | -5.21 | -2.43 | -3.14 |
| EPS Diluted | 0.02 | 0.04 | -0.02 | -0.02 | -0.05 | 0.05 | 0.04 | -0.06 | -0.13 | -0.37 | -0.04 | -0.42 | -0.50 | -0.67 | -0.47 | -0.35 | -0.17 | -0.37 | -0.44 | -1.55 | -0.60 | -0.79 | -0.87 | -2.68 | -1.43 | 1.85 | 2.00 | 2.00 | 2.00 | 0.00 | 0.64 | -2.93 | -17.07 | -3.57 | -1.14 | -5.21 | -2.43 | -3.14 |
| Weighted Avg Shares Out | 70.32M | 70.32M | 70.32M | 70.22M | 70.22M | 73.93M | 16.03M | 7.19M | 6.19M | 3.79M | 2.98M | 244.01K | 243.40K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 187.96K | 140.00K | 130.00K | 130.00K | 130.00K | 130.00K | 130.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K |
| Weighted Avg Shares Out (Dil) | 77.86M | 77.86M | 70.32M | 70.22M | 70.22M | 73.93M | 19.47M | 9.21M | 6.19M | 3.79M | 2.98M | 244.01K | 243.40K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 235.80K | 187.96K | 140.00K | 130.00K | 130.00K | 130.00K | 130.00K | 130.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K | 140.00K |
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
RICHARDSON, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) -- On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its quarterly report...
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the official launch of the FuseChoice™ Dermal Matrix line (“FuseChoice™ Derm”). This is...
Fuse Medical, Inc. Announces Initial Launch of Orbitum™ Compression Staple System
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch and first implantations of the Fuse Orbitum™ Compression Staple. This...
Fuse Medical, Inc. Announces First Quarter 2021 Financial Results
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the quarter...
Fuse Medical, Inc. Announces First Quarter 2021 Financial Results
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the quarter...
Fuse Medical, Inc. Announces Fiscal Year 2020 Financial Results
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its annual report on Form 10-K for the year...
Fuse Medical, Inc. Announces Exclusive Agreement With Orthovestments, LLC for Manufacturing & Commercialization of the Orbitum™ Staple System
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced today an agreement with Orthovestments, LLC for the exclusive manufacturing and commercialization of...
Fuse Medical, Inc. Enters Into Marketing Agreement With CarePICS Telehealth
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced today an agreement with CarePICS, the latest resource addition to Fuse's comprehensive portfolio...
Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch of FuseChoiceTM and FuseChoiceTM Plus Amniotic & Umbilical Membranes, and...
Fuse Medical, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) announced that it filed its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020 with the Securities and Exchange Commission (“SEC”) on Monday, November 16,...
Source: https://incomestatements.info
Category: Stock Reports